TY - JOUR
T1 - Effectiveness of propolis with artemisinin combination therapy in treating mice infected with plasmodium berghei
AU - Trisnaningrum, Nurindah Saloka
AU - Astuty, Hendri
N1 - Publisher Copyright:
© 2019 The Authors.
PY - 2019/4/1
Y1 - 2019/4/1
N2 - Objective: This study aimed to ascertain the effectiveness of combination treatment with propolis and artemisinin-based combination therapy (ACT) in avoiding further resistance to ACT. Methods: A total of 35 mice were injected with Plasmodium berghei and divided into six equal groups: No treatment (negative control), ACT alone (positive control), 75-mg propolis/kg body weight (BW), 150-mg propolis/kg BW, ACT with 75-mg propolis/kg BW, and ACT with 150-mg propolis/ kg BW. After 7 days of therapy, parasite density was calculated using a thin blood smear. Results: Parasite density significantly declined after combination treatment with ACT and 150-mg propolis/kg BW. Conclusion: Therapy with propolis alone showed no inhibitory effect on parasites, although its 150-mg/kg-BW dose was effective as an ACT adjuvant malaria therapy in mice.
AB - Objective: This study aimed to ascertain the effectiveness of combination treatment with propolis and artemisinin-based combination therapy (ACT) in avoiding further resistance to ACT. Methods: A total of 35 mice were injected with Plasmodium berghei and divided into six equal groups: No treatment (negative control), ACT alone (positive control), 75-mg propolis/kg body weight (BW), 150-mg propolis/kg BW, ACT with 75-mg propolis/kg BW, and ACT with 150-mg propolis/ kg BW. After 7 days of therapy, parasite density was calculated using a thin blood smear. Results: Parasite density significantly declined after combination treatment with ACT and 150-mg propolis/kg BW. Conclusion: Therapy with propolis alone showed no inhibitory effect on parasites, although its 150-mg/kg-BW dose was effective as an ACT adjuvant malaria therapy in mice.
KW - Artemisinin-based combination therapy
KW - Malaria
KW - Plasmodium berghei
KW - Propolis
UR - http://www.scopus.com/inward/record.url?scp=85067922372&partnerID=8YFLogxK
U2 - 10.22159/ijap.2019.v11s1.012
DO - 10.22159/ijap.2019.v11s1.012
M3 - Article
AN - SCOPUS:85067922372
SN - 0975-7058
VL - 11
SP - 262
EP - 264
JO - International Journal of Applied Pharmaceutics
JF - International Journal of Applied Pharmaceutics
ER -